Literature DB >> 3339243

Immunoglobulins and complement in demyelination induced in mice by Theiler's virus.

M Rodriguez1, C F Lucchinetti, R J Clark, T L Yakash, H Markowitz, V A Lennon.   

Abstract

Intracerebral inoculation of Theiler's murine encephalomyelitis virus (TMEV) produces chronic demyelination and persistent infection in the central nervous system (CNS) of susceptible SJL mice. This series of experiments examined the contribution of humoral immunity and C to myelin destruction. As in multiple sclerosis, mice persistently infected with TMEV had elevated levels of IgG and oligoclonal bands in the cerebrospinal fluid (CSF). Immunoblot studies revealed that even in animals exhibiting profound demyelination, IgG in the serum and CSF was directed primarily at virus antigen rather than at normal myelin components. Inflammatory cells positive for Ig were distributed mainly around blood vessels, but occasionally they infiltrated the spinal cord parenchyma. Rare examples of myelin sheaths positive for IgG were found by immunoelectron microscopy in spinal cord sections from infected mice; the third component of complement (C3) was commonly found in the walls of CNS blood vessels but not on myelin. Neither serum nor CSF IgG from infected mice bound to myelin sheaths or other CNS components in sections of normal syngeneic spinal cord. There were significantly more demyelinating lesions in infected mice depleted of C components with cobra venom factor. These data do not support a humoral autoimmune basis for the CNS demyelination that occurs in association with persistent TMEV infection. However, the humoral immune response directed at TMEV antigens may either limit virus spread or promote virus persistence.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3339243

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system.

Authors:  J F Bureau; X Montagutelli; S Lefebvre; J L Guénet; M Pla; M Brahic
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  ICAM-1 is crucial for protection from TMEV-induced neuronal damage but not demyelination.

Authors:  Kristen M Drescher; Laurie J Zoecklein; Moses Rodriguez
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

3.  Treatment of Theiler's virus-induced demyelinating disease with teriflunomide.

Authors:  Francesca Gilli; Libin Li; Darlene B Royce; Krista D DiSano; Andrew R Pachner
Journal:  J Neurovirol       Date:  2017-09-14       Impact factor: 2.643

4.  Role for complement in the development of seizures following acute viral infection.

Authors:  Jane E Libbey; Nikki J Kirkman; Karen S Wilcox; H Steve White; Robert S Fujinami
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

5.  HLA-DQ polymorphism influences progression of demyelination and neurologic deficits in a viral model of multiple sclerosis.

Authors:  K D Pavelko; K M Drescher; D B McGavern; C S David; M Rodriguez
Journal:  Mol Cell Neurosci       Date:  2000-06       Impact factor: 4.314

Review 6.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

Review 7.  CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies.

Authors:  A Arévalo-Martín; D García-Ovejero; O Gómez; A Rubio-Araiz; B Navarro-Galve; C Guaza; E Molina-Holgado; F Molina-Holgado
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

8.  B-lymphocyte requirement for vaccine-mediated protection from Theiler's murine encephalomyelitis virus-induced central nervous system disease.

Authors:  C I Kurtz; X M Sun; R S Fujinami
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

Review 9.  Immunology of Theiler's murine encephalomyelitis virus infection.

Authors:  E L Oleszak; J Kuzmak; R A Good; C D Platsoucas
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

10.  IL-1, IL-2 and IFN-gamma production by Theiler's virus-induced encephalomyelitic SJL/J mice.

Authors:  N Rubio; C Torres
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.